HARVARD BIOSCIENCE INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Harvard Bioscience Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Harvard Bioscience Inc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $2.92M, a 61.1% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.92M -$4.59M -61.1% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $3.24M -$3.18M -49.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.79M -$3.16M -39.7% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $6.47M -$1.31M -16.8% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $7.51M -$793K -9.55% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $6.41M -$2.28M -26.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $7.94M +$2.68M +51% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 $7.78M +$2.41M +44.7% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $8.31M +$7.58M +1047% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $8.69M +$7.88M +973% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $5.26M +$4.45M +548% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $5.38M +$4.28M +392% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $724K -$1.17M -61.8% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $810K -$933K -53.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $812K -$1.07M -56.8% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $1.09M -$1.18M -52% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $1.9M +$1.58M +493% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $1.74M +$1.55M +813% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.88M +$632K +50.6% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $2.27M +$458K +25.2% Dec 31, 2019 10-K/A 2021-03-17
Q3 2019 $320K -$1.47M -82.1% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $191K -$1.1M -85.2% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.25M -$103K -7.62% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $1.82M +$1.49M +460% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $1.79M +$1.67M +1381% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $1.29M +$1.16M +888% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $1.35M +$1.21M +839% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $324K +$196K +153% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $121K +$9K +8.04% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $131K +$37K +39.4% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $144K +$12K +9.09% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $128K -$24K -15.8% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $112K -$237K -67.9% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $94K -$312K -76.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $132K -$220K -62.5% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $152K -$228K -60% Dec 31, 2015 10-K 2017-03-17
Q3 2015 $349K -$10K -2.79% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $406K +$28K +7.41% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $352K +$60K +20.5% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $380K +$64K +20.3% Dec 31, 2014 10-K 2016-04-29
Q3 2014 $359K +$13K +3.76% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $378K +$7K +1.89% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $292K -$526K -64.3% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $316K -$174K -35.5% Dec 31, 2013 10-K 2015-03-12
Q3 2013 $346K +$279K +416% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $371K +$261K +237% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $818K +$655K +402% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $490K +$275K +128% Dec 31, 2012 10-K 2014-03-14
Q3 2012 $67K -$179K -72.8% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $110K -$176K -61.5% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $163K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $215K -$145K -40.3% Dec 31, 2011 10-K 2013-03-18
Q3 2011 $246K Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $286K Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $360K Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.